Te Ahumairangi Investment Management Ltd purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 13,092 shares of the company's stock, valued at approximately $5,104,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare in the 3rd quarter valued at about $26,000. MidFirst Bank acquired a new stake in HCA Healthcare during the second quarter worth approximately $28,000. Clearstead Trust LLC bought a new stake in HCA Healthcare in the 2nd quarter valued at $29,000. Ares Financial Consulting LLC bought a new position in shares of HCA Healthcare during the fourth quarter worth approximately $31,000. Finally, Cedar Mountain Advisors LLC bought a new position in HCA Healthcare during the 1st quarter worth $33,000. Institutional investors own 62.73% of the company's stock.
Analyst Ratings Changes
A number of brokerages have issued reports on HCA. Argus reduced their price objective on shares of HCA Healthcare from $560.00 to $500.00 and set a "buy" rating on the stock in a research note on Monday, May 4th. Cantor Fitzgerald decreased their price target on HCA Healthcare from $588.00 to $525.00 and set an "overweight" rating on the stock in a research note on Tuesday, July 7th. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $435.00 price target on shares of HCA Healthcare in a report on Monday, July 27th. Oppenheimer dropped their price target on HCA Healthcare from $520.00 to $485.00 and set an "outperform" rating for the company in a research note on Monday, July 27th. Finally, Truist Financial lowered their price objective on HCA Healthcare from $535.00 to $495.00 and set a "buy" rating for the company in a research note on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $462.64.
Read Our Latest Analysis on HCA
HCA Healthcare Price Performance
Shares of HCA opened at $429.08 on Monday. The company has a market cap of $92.90 billion, a PE ratio of 14.36, a P/E/G ratio of 1.49 and a beta of 1.10. The stock has a 50-day moving average of $397.16 and a 200-day moving average of $443.77. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period last year, the firm earned $6.84 earnings per share. The business's quarterly revenue was up 8.7% compared to the same quarter last year. Analysts expect that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's dividend payout ratio is 10.45%.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
